164 related articles for article (PubMed ID: 35391593)
1. The dilemma of routine testing for calcitonin thyroid nodule's patients to detect or exclude medullary carcinoma: one single negative test should be valuable as rule-out strategy to avoid further calcitonin measurements over time.
Trimboli P; Camponovo C; Ruinelli L
Endocrine; 2022 Jun; 77(1):80-85. PubMed ID: 35391593
[TBL] [Abstract][Full Text] [Related]
2. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
3. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
4. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
5. Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays.
Faggiano A; Giannetta E; Modica R; Albertelli M; Barba L; Dolce P; Motta C; Deiana MG; Martinelli R; Zamponi V; Sesti F; Patti L; Scavuzzo F; Colao A; Monti S
Minerva Endocrinol (Torino); 2023 Sep; 48(3):253-260. PubMed ID: 37326573
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
7. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
Trimboli P; Giovanella L
Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.
Verbeek HH; de Groot JWB; Sluiter WJ; Muller Kobold AC; van den Heuvel ER; Plukker JT; Links TP
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD010159. PubMed ID: 32176812
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value and cost-effectiveness of FNA-CT versus FNAC for medullary thyroid carcinoma.
Wang M; Chen H; Wang Y; Lei J; Li Z
Clin Endocrinol (Oxf); 2023 May; 98(5):709-718. PubMed ID: 36394172
[TBL] [Abstract][Full Text] [Related]
12. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
Kartal Baykan E; Erdoğan M
Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules.
Giovanella L; Verburg FA; Imperiali M; Valabrega S; Trimboli P; Ceriani L
Clin Chem Lab Med; 2013 Jul; 51(7):1477-81. PubMed ID: 23314540
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer.
Diazzi C; Madeo B; Taliani E; Zirilli L; Romano S; Granata AR; De Santis MC; Simoni M; Cioni K; Carani C; Rochira V
Endocr Pract; 2013; 19(5):769-79. PubMed ID: 23757613
[TBL] [Abstract][Full Text] [Related]
16. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.
Papi G; Corsello SM; Cioni K; Pizzini AM; Corrado S; Carapezzi C; Fadda G; Baldini A; Carani C; Pontecorvi A; Roti E
J Endocrinol Invest; 2006 May; 29(5):427-37. PubMed ID: 16794366
[TBL] [Abstract][Full Text] [Related]
17. Thresholds of Basal- and Calcium-Stimulated Calcitonin for Diagnosis of Thyroid Malignancy.
Băetu M; Olariu CA; Stancu C; Caragheorgheopol A; Ioachim D; Moldoveanu G; Corneci C; Badiu C
Horm Metab Res; 2021 Dec; 53(12):779-786. PubMed ID: 34687025
[TBL] [Abstract][Full Text] [Related]
18. [Early diagnosis of sporadic medullary cancers of the thyroid: value of systematic assay of calcitonin].
Henry JF; Denizot A; Puccini M; Niccoli P; Conte-Devolx B; de Micco C
Presse Med; 1996 Nov; 25(33):1583-8. PubMed ID: 8952672
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M
Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993
[TBL] [Abstract][Full Text] [Related]
20. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
